Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 4, 1999, Pages 483-487

  Kashimura, H ^a   Suzuki, K ^a   Hassan, M ^a   Ikezawa, K ^a   Sawahata, T ^b   Watanabe, T ^a   Nakahara, A ^a   Mutoh, H ^a   Tanaka, N ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; GASTROINTESTINAL MUCOSA PROTECTIVE AGENT; LANSOPRAZOLE; POLAPREZINC;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; TASTE DISORDER;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CARNOSINE; CLARITHROMYCIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PATIENT COMPLIANCE; PENICILLINS; PROSPECTIVE STUDIES; PROTECTIVE AGENTS;

EID: 0032942937     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00510.x     Document Type: Article

References (20)

1. Forbes GM, Glaser ME, Cullen DJE, et al. Duodenal ulcer treated with Helicobacter pylori eradication: Seven-year follow-up. Lancet 1994; 343: 258-60.
2. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long term recurrence of gastric or duodenal ulcer. Ann Intern Med 1992; 116: 705-8.
3. Riff DS, Rose P, Haber M, Weissfeld A, Siepman N. Triple therapy with lansoprazole, clarithromycin, and amoxicillin for the cure of Helicobacter pylori infection: A short report. Helicobacter 1996; 1: 238-42.
4. Lamouliatte H. Adjuvant therapy for Helicobacter pylori eradication: Role of lansoprazole in clinical studies. J Clin Gastroenterol 1995; 20(Suppl. 1): S28-31.
5. Seiki M, Ueki S, Tanaka Y, et al. Studies on anti-ulcer effects of a new compound, zinc L-carnosine (Z103). Folia Pharmacol Japan 1990; 95: 257-69 (in Japanese).
6. Sunairi M, Watanabe K, Suzuki T, et al. Effects of anti-ulcer agents on antibiotic activity against Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6(Suppl. 1): S121-4.
7. Sunairi M, Tanaka N, Kuwayama H, Nakajima M. Effect of Z-103, a new antiulcer agent, on Helicobacter pylori - Antimicrobial, antiurease, and antiadhesive activities. Jpn Pharmacol Ther 1994; 22(9): 31-5.
8. Kuwayama H. Zinc compound is a novel, highly effective triple therapy for eradication of Helicobacter pylori. Gastroenterology 1995; 108: A139(Abstract).
9. Go MF, Fennerty MB. Treatment of Helicobacter pylori infection. Current Opinion in Gastroenterology 1998; 14: 64-9.
10. Logan RPH, Gummett PA, Schaufelberger HD, et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994; 35: 323-6.
11. Harris AW, Gummett PA, Logan RPH, et al. Eradication of Helicobacter pylori with lansoprazole and clarithromycin. Aliment Pharmacol Ther 1995; 9: 201-4.
12. Well J, Bell DG, Powell K, et al. Omeprazole and Helicobacter pylori: Temporary suppression rather than true eradication. Aliment Pharmacol Ther 1991; 5: 309-13.
13. Westblom TU, Duriex D. Enhancement of antibiotic concentrations in gastric mucosa by H2-receptor antagonist. Implications for treatment of Helicobacter pylori infections. Dig Dis Sci 1991; 36: 25-8.
14. Iwahi T, Satoh H, Nakao M, et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against H. pylori. Antimicrob Agents Chemother 1991; 35: 490-6.
15. Mcgraud F, Boyanova L, Lamouliatte H. Activity of lansoprazole against Helicobacter pylori. Lancet 1991; 537: 1486.
16. Schutze K, Hentschel E. Duodenal ulcer healing after 7-day treatment: A pilot study with lansoprazole, amoxicillin and clarithromycin. Z Gastroenterol 1995; 33: 651-3.
17. Hara H, Shibata Y, Okamura T, et al. Experimental studies on binding of Z-103 to gastric ulcer in the dog. Ther Res 1991; 12: 3239-41.
18. ABPI Data Sheet Compendium. London: Datapharm Publications Ltd, 1995.
19. Logan RPH, Gummett PA, Schaufelberger HD, et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994; 35: 323-6.
20. Weldon MJ, Broadbent A, Chambers S, et al. A 7-day Helicobacter pylori treatment regimen using clarithromycin, omeprazole and bismuth chelate. Aliment Pharmacol Ther 1996; 10: 279-83.